NATAP: Etravirine Efficacy/Safety/Resistance/Tolerability

[Guest guest]

Here is the most recent publicly presented data on etravirine (TMC-125) efficacy, impact of NNRTI mutations, safety, and tolerability reported at -

11th European AIDS Conference

Madrid

October 24-27, 2007

Pooled 24-week results of DUET-1 and DUET-2: TMC125 (etravirine; ETR) safety and tolerability in treatment-experienced, HIV-1-infected patients (10/26/06)

Pooled 24-week results of DUET-1 and DUET-2: efficacy of TMC125 (etravirine; ETR) in treatment-experienced HIV-1-infected patients (10/26/06)

Impact of baseline NNRTI mutations on the virological response to TMC125 (etravirine; ETR) in the DUET-1 and DUET-2 Phase III clinical trials (10/26/06)

An Open, Randomized, Two-Period, Crossover Study in Two Cohorts to Investigate the Effect of Steady-State TMC125 (etravirine) and the Combination of TMC125/Darunavir/Ritonavir on the Steady-State Pharmacokinetics of Oral Maraviroc in Healthy Subjects - (11/29/06)

**************Start the year off right. Easy ways to stay in shape. http://body.aol.com/fitness/winter-exercise?NCID=aolcmp00300000002489